BDBM277529 US10072026, Example 4-20::US10947254, Example 4-20::US11780852, Example 4-20

SMILES CCC1(S(=O)(=O)N2[C@@H]3CCC[C@H]2C[C@H](Nc2nc(Nc4cc(C)[nH]n4)cc4ncccc24)C3)CC1

InChI Key InChIKey=DOZPDLPJZIRZNS-UHFFFAOYSA-N

Data  12 KI

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 16 hits for monomerid = 277529   

TargetTyrosine-protein kinase JAK2(Human)
Theravance Biopharma R&D IP

US Patent

LigandBDBM277529(US10072026, Example 4-20 | US10947254, Example 4-2...)Copy SMILESCopy InChI

Affinity DataKi: <0.100nMAssay Description:A panel of four LanthaScreen JAK biochemical assays (JAK1, 2, 3 and Tyk2) were carried in a common kinase reaction buffer (50 mM HEPES, pH 7.5, 0.01%...More data for this Ligand-Target Pair

Target InfoPDBKEGG
UniProtKB/SwissProt
GoogleScholar

Ligand InfoPC cidPC sidSimilars

In Depth
Date in BDB:
10/29/2025
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL

TargetTyrosine-protein kinase JAK2(Human)
Theravance Biopharma R&D IP

US Patent

LigandBDBM277529(US10072026, Example 4-20 | US10947254, Example 4-2...)Copy SMILESCopy InChI

Affinity DataKi: <0.100nMAssay Description:Biochemical JAK and Off-Target Kinase Assays. A panel of four LanthaScreen JAK biochemical assays (JAK1, 2, 3 and Tyk2) were carried in a common kin...More data for this Ligand-Target Pair

Target InfoPDBKEGG
UniProtKB/SwissProt
GoogleScholar

Ligand InfoPC cidPC sidSimilars

In Depth
Date in BDB:
11/17/2023
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL

TargetTyrosine-protein kinase JAK2(Human)
Theravance Biopharma R&D IP

US Patent

LigandBDBM277529(US10072026, Example 4-20 | US10947254, Example 4-2...)Copy SMILESCopy InChI

Affinity DataKi: <0.100nMpH: 7.5Assay Description:A panel of four LanthaScreen JAK biochemical assays (JAK1, 2, 3 and Tyk2) were carried in a common kinase reaction buffer (50 mM HEPES, pH 7.5, 0.01%...More data for this Ligand-Target Pair

Target InfoPDBKEGG
UniProtKB/SwissProt
GoogleScholar

Ligand InfoPC cidPC sidSimilars

In Depth
Date in BDB:
12/21/2018
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL

TargetTyrosine-protein kinase JAK2(Human)
Theravance Biopharma R&D IP

US Patent

LigandBDBM277529(US10072026, Example 4-20 | US10947254, Example 4-2...)Copy SMILESCopy InChI

Affinity DataKi: <0.100nMAssay Description:A panel of four LanthaScreen JAK biochemical assays (JAK1, 2, 3 and Tyk2) were carried in a common kinase reaction buffer (50 mM HEPES, pH 7.5, 0.01%...More data for this Ligand-Target Pair

Target InfoPDBKEGG
UniProtKB/SwissProt
GoogleScholar

Ligand InfoPC cidPC sidSimilars

In Depth
Date in BDB:
9/28/2021
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL

TargetTyrosine-protein kinase JAK3(Human)
Theravance Biopharma R&D IP

US Patent

LigandBDBM277529(US10072026, Example 4-20 | US10947254, Example 4-2...)Copy SMILESCopy InChI

Affinity DataKi:  0.550nMAssay Description:A panel of four LanthaScreen JAK biochemical assays (JAK1, 2, 3 and Tyk2) were carried in a common kinase reaction buffer (50 mM HEPES, pH 7.5, 0.01%...More data for this Ligand-Target Pair

Target InfoPDBKEGG
UniProtKB/SwissProtUniProtKB/TrEMBL
GoogleScholar

Ligand InfoPC cidPC sidSimilars

In Depth
Date in BDB:
10/29/2025
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Theravance Biopharma R&D IP

US Patent

LigandBDBM277529(US10072026, Example 4-20 | US10947254, Example 4-2...)Copy SMILESCopy InChI

Affinity DataKi:  0.550nMAssay Description:A panel of four LanthaScreen JAK biochemical assays (JAK1, 2, 3 and Tyk2) were carried in a common kinase reaction buffer (50 mM HEPES, pH 7.5, 0.01%...More data for this Ligand-Target Pair

Target InfoPDBKEGG
UniProtKB/SwissProt
GoogleScholar

Ligand InfoPC cidPC sidSimilars

In Depth
Date in BDB:
10/29/2025
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL

TargetTyrosine-protein kinase JAK1(Human)
Theravance Biopharma R&D IP

US Patent

LigandBDBM277529(US10072026, Example 4-20 | US10947254, Example 4-2...)Copy SMILESCopy InChI

Affinity DataKi:  0.550nMAssay Description:A panel of four LanthaScreen JAK biochemical assays (JAK1, 2, 3 and Tyk2) were carried in a common kinase reaction buffer (50 mM HEPES, pH 7.5, 0.01%...More data for this Ligand-Target Pair

Target InfoPDBKEGG
UniProtKB/SwissProt
GoogleScholar

Ligand InfoPC cidPC sidSimilars

In Depth
Date in BDB:
10/29/2025
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL

TargetTyrosine-protein kinase JAK1(Human)
Theravance Biopharma R&D IP

US Patent

LigandBDBM277529(US10072026, Example 4-20 | US10947254, Example 4-2...)Copy SMILESCopy InChI

Affinity DataKi:  0.550nMAssay Description:Biochemical JAK and Off-Target Kinase Assays. A panel of four LanthaScreen JAK biochemical assays (JAK1, 2, 3 and Tyk2) were carried in a common kin...More data for this Ligand-Target Pair

Target InfoPDBKEGG
UniProtKB/SwissProt
GoogleScholar

Ligand InfoPC cidPC sidSimilars

In Depth
Date in BDB:
11/17/2023
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL

TargetTyrosine-protein kinase JAK1(Human)
Theravance Biopharma R&D IP

US Patent

LigandBDBM277529(US10072026, Example 4-20 | US10947254, Example 4-2...)Copy SMILESCopy InChI

Affinity DataKi:  0.550nMpH: 7.5Assay Description:A panel of four LanthaScreen JAK biochemical assays (JAK1, 2, 3 and Tyk2) were carried in a common kinase reaction buffer (50 mM HEPES, pH 7.5, 0.01%...More data for this Ligand-Target Pair

Target InfoPDBKEGG
UniProtKB/SwissProt
GoogleScholar

Ligand InfoPC cidPC sidSimilars

In Depth
Date in BDB:
12/21/2018
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Theravance Biopharma R&D IP

US Patent

LigandBDBM277529(US10072026, Example 4-20 | US10947254, Example 4-2...)Copy SMILESCopy InChI

Affinity DataKi:  0.550nMAssay Description:A panel of four LanthaScreen JAK biochemical assays (JAK1, 2, 3 and Tyk2) were carried in a common kinase reaction buffer (50 mM HEPES, pH 7.5, 0.01%...More data for this Ligand-Target Pair

Target InfoPDBKEGG
UniProtKB/SwissProt
GoogleScholar

Ligand InfoPC cidPC sidSimilars

In Depth
Date in BDB:
9/28/2021
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL

TargetTyrosine-protein kinase JAK3(Human)
Theravance Biopharma R&D IP

US Patent

LigandBDBM277529(US10072026, Example 4-20 | US10947254, Example 4-2...)Copy SMILESCopy InChI

Affinity DataKi:  0.550nMAssay Description:A panel of four LanthaScreen JAK biochemical assays (JAK1, 2, 3 and Tyk2) were carried in a common kinase reaction buffer (50 mM HEPES, pH 7.5, 0.01%...More data for this Ligand-Target Pair

Target InfoPDBKEGG
UniProtKB/SwissProtUniProtKB/TrEMBL
GoogleScholar

Ligand InfoPC cidPC sidSimilars

In Depth
Date in BDB:
9/28/2021
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL

TargetTyrosine-protein kinase JAK3(Human)
Theravance Biopharma R&D IP

US Patent

LigandBDBM277529(US10072026, Example 4-20 | US10947254, Example 4-2...)Copy SMILESCopy InChI

Affinity DataKi:  0.550nMpH: 7.5Assay Description:A panel of four LanthaScreen JAK biochemical assays (JAK1, 2, 3 and Tyk2) were carried in a common kinase reaction buffer (50 mM HEPES, pH 7.5, 0.01%...More data for this Ligand-Target Pair

Target InfoPDBKEGG
UniProtKB/SwissProtUniProtKB/TrEMBL
GoogleScholar

Ligand InfoPC cidPC sidSimilars

In Depth
Date in BDB:
12/21/2018
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL

TargetTyrosine-protein kinase JAK1(Human)
Theravance Biopharma R&D IP

US Patent

LigandBDBM277529(US10072026, Example 4-20 | US10947254, Example 4-2...)Copy SMILESCopy InChI

Affinity DataKi:  0.550nMAssay Description:A panel of four LanthaScreen JAK biochemical assays (JAK1, 2, 3 and Tyk2) were carried in a common kinase reaction buffer (50 mM HEPES, pH 7.5, 0.01%...More data for this Ligand-Target Pair

Target InfoPDBKEGG
UniProtKB/SwissProt
GoogleScholar

Ligand InfoPC cidPC sidSimilars

In Depth
Date in BDB:
9/28/2021
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Theravance Biopharma R&D IP

US Patent

LigandBDBM277529(US10072026, Example 4-20 | US10947254, Example 4-2...)Copy SMILESCopy InChI

Affinity DataKi:  0.550nMpH: 7.5Assay Description:A panel of four LanthaScreen JAK biochemical assays (JAK1, 2, 3 and Tyk2) were carried in a common kinase reaction buffer (50 mM HEPES, pH 7.5, 0.01%...More data for this Ligand-Target Pair

Target InfoPDBKEGG
UniProtKB/SwissProt
GoogleScholar

Ligand InfoPC cidPC sidSimilars

In Depth
Date in BDB:
12/21/2018
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL

TargetTyrosine-protein kinase JAK3(Human)
Theravance Biopharma R&D IP

US Patent

LigandBDBM277529(US10072026, Example 4-20 | US10947254, Example 4-2...)Copy SMILESCopy InChI

Affinity DataKi:  0.550nMAssay Description:Biochemical JAK and Off-Target Kinase Assays. A panel of four LanthaScreen JAK biochemical assays (JAK1, 2, 3 and Tyk2) were carried in a common kin...More data for this Ligand-Target Pair

Target InfoPDBKEGG
UniProtKB/SwissProtUniProtKB/TrEMBL
GoogleScholar

Ligand InfoPC cidPC sidSimilars

In Depth
Date in BDB:
11/17/2023
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Theravance Biopharma R&D IP

US Patent

LigandBDBM277529(US10072026, Example 4-20 | US10947254, Example 4-2...)Copy SMILESCopy InChI

Affinity DataKi:  0.550nMAssay Description:Biochemical JAK and Off-Target Kinase Assays. A panel of four LanthaScreen JAK biochemical assays (JAK1, 2, 3 and Tyk2) were carried in a common kin...More data for this Ligand-Target Pair

Target InfoPDBKEGG
UniProtKB/SwissProt
GoogleScholar

Ligand InfoPC cidPC sidSimilars

In Depth
Date in BDB:
11/17/2023
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL